H. Tsuda

653 total citations
15 papers, 554 citations indexed

About

H. Tsuda is a scholar working on Cancer Research, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, H. Tsuda has authored 15 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in H. Tsuda's work include Breast Cancer Treatment Studies (5 papers), Breast Lesions and Carcinomas (4 papers) and Gastrointestinal disorders and treatments (2 papers). H. Tsuda is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Breast Lesions and Carcinomas (4 papers) and Gastrointestinal disorders and treatments (2 papers). H. Tsuda collaborates with scholars based in Japan, United States and United Kingdom. H. Tsuda's co-authors include Takeo Fukuchi, S Hirohashi, Masato Sakamoto, Kouji Maruyama, Shiari Nozawa, S Hirohashi, Michiie Sakamoto, Yae Kanai, Yuko Sasajima and Ryota Tanaka and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and British Journal of Cancer.

In The Last Decade

H. Tsuda

15 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Tsuda Japan	9	343	180	103	97	83	15	554
Enno Dreef Netherlands	11	143 0.4×	190 1.1×	112 1.1×	204 2.1×	26 0.3×	14	489
Kim McManus United States	9	120 0.3×	107 0.6×	126 1.2×	94 1.0×	54 0.7×	10	396
Sandeep Reddy United States	8	159 0.5×	222 1.2×	138 1.3×	150 1.5×	19 0.2×	18	458
Shivakumar Subramaniyam United States	10	350 1.0×	177 1.0×	144 1.4×	147 1.5×	20 0.2×	21	624
E Patsouris Greece	13	166 0.5×	156 0.9×	89 0.9×	76 0.8×	29 0.3×	31	393
Alba Mota Spain	9	226 0.7×	52 0.3×	104 1.0×	40 0.4×	47 0.6×	13	364
Bárbara Alemar Brazil	13	196 0.6×	175 1.0×	166 1.6×	68 0.7×	16 0.2×	19	405
Laura López-Vicente Spain	4	265 0.8×	166 0.9×	88 0.9×	54 0.6×	21 0.3×	4	480
Terri Woo United States	7	135 0.4×	129 0.7×	85 0.8×	36 0.4×	20 0.2×	8	394
Yoshikazu Sasaki Japan	11	94 0.3×	184 1.0×	87 0.8×	272 2.8×	29 0.3×	23	491

Countries citing papers authored by H. Tsuda

Since Specialization

Citations

This map shows the geographic impact of H. Tsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Tsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Tsuda more than expected).

Fields of papers citing papers by H. Tsuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Tsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Tsuda. The network helps show where H. Tsuda may publish in the future.

Co-authorship network of co-authors of H. Tsuda

This figure shows the co-authorship network connecting the top 25 collaborators of H. Tsuda. A scholar is included among the top collaborators of H. Tsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Tsuda. H. Tsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kinoshita, T., M Takahashi, Tomomi Fujisawa, et al.. (2018). Radiofrequency ablation therapy for early-stage breast cancer: Results from 5 years of follow-up in a prospective multicenter study. European Journal of Cancer. 92. S63–S63. 1 indexed citations

Tanaka, Ryota, Yuko Sasajima, H. Tsuda, et al.. (2013). Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease. British Journal of Dermatology. 168(6). 1259–1266. 53 indexed citations

Mukaihara, Kenta, Akihiko Yoshida, Yoshiyuki Suehara, et al.. (2013). The Prognostic Value of Pfetin: A Validation Study in Gastrointestinal Stromal Tumors Using a Commercially Available Antibody. Japanese Journal of Clinical Oncology. 43(6). 669–675. 8 indexed citations

Okubo, Taketo, Yoshiyuki Suehara, Akihiko Yoshida, et al.. (2012). Validation Study on Pfetin and ATP-dependent RNA Helicase DDX39 as Prognostic Biomarkers in Gastrointestinal Stromal Tumour. Japanese Journal of Clinical Oncology. 42(8). 730–741. 19 indexed citations

Hasebe, Takahiro, Motoki Iwasaki, Sadako Akashi‐Tanaka, et al.. (2011). Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast. British Journal of Cancer. 105(5). 698–708. 4 indexed citations

Noguchi, Sanai, H. Tsuda, Takayuki Kinoshita, et al.. (2011). Multi-institutional evaluation of sentinel lymph node (SLN) examination by one-step nucleic acid amplification (OSNA) assay in breast cancer: Performance of metastases detection and prediction of additional non-sentinel lymph node (non-SLN) involvement.. Journal of Clinical Oncology. 29(15_suppl). 1040–1040. 2 indexed citations

Hasebe, Takahiro, Motoki Iwasaki, Sadako Akashi‐Tanaka, et al.. (2010). Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast. Human Pathology. 41(5). 706–715. 11 indexed citations

Hasebe, Takahiro, Nobuko Tamura, Motoki Iwasaki, et al.. (2010). Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy. Modern Pathology. 23(4). 581–592. 11 indexed citations

Hasebe, Takahiro, Nobuko Tamura, Takashi Hojo, et al.. (2009). p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapy. Human Pathology. 41(2). 262–270. 19 indexed citations

10.

Hasebe, Takahiro, Nobuko Tamura, Sadako Akashi‐Tanaka, et al.. (2009). p53 expression in tumor stromal fibroblasts is associated with the outcome of patients with invasive ductal carcinoma of the breast. Cancer Science. 100(11). 2101–2108. 15 indexed citations

11.

Takeuchi, Kazuhiko, et al.. (2001). [Therapeutic plasmapheresis for the prevention of congenital complete heart block associated with anti-SS-A/Ro antibody and anti-SS-B/La antibody].. PubMed. 41(4). 726–35. 12 indexed citations

12.

Teng, Chong, Masahiko Negishi, K. Shimazaki, et al.. (2000). Lactoferrin gene: methylation, expression and cancer.. 247–255. 2 indexed citations

13.

Fukuchi, Takeo, Masato Sakamoto, H. Tsuda, et al.. (1998). Beta-catenin mutation in carcinoma of the uterine endometrium.. PubMed. 58(16). 3526–8. 320 indexed citations

14.

Kanai, Yae, et al.. (1997). Reduced P21Waf1/Cip1 Expression and P53 Mutation in Hepatocellular Carcinomas. Hepatology. 25(3). 575–579. 70 indexed citations

15.

Hirohashi, S, et al.. (1988). Detection of amplified N-myc gene in neuroblastoma by in situ hybridization using the single-step silver enhancement method.. PubMed. 1(6). 428–32. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact